- MNTA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $13.2 million.
- MNTA traded 82,160 shares today in the pre-market hours as of 8:19 AM, representing 12.2% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in MNTA with the Ticky from Trade-Ideas. See the FREE profile for MNTA NOW at Trade-Ideas More details on MNTA: Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. Currently there are 4 analysts that rate Momenta Pharmaceuticals a buy, 1 analyst rates it a sell, and 1 rates it a hold. The average volume for Momenta Pharmaceuticals has been 973,700 shares per day over the past 30 days. Momenta has a market cap of $1.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.88 and a short float of 13.5% with 11.75 days to cover. Shares are up 67.9% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.